Immunotarget Therapeutics Inc.

UEI
RKHMXCMM1SA3
CAGE
8SAS0
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Immunotarget Therapeutics Inc.'s latest federal award, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Sbir innovative concept award - detection, diagnosis, treatment, prevention and research of pediatric cancers and/or… Contract · 75N91022C00004 National Cancer Institute $355,000

Quick answers

What is Immunotarget Therapeutics Inc.'s UEI?

Immunotarget Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is RKHMXCMM1SA3.

What is Immunotarget Therapeutics Inc.'s CAGE code?

Immunotarget Therapeutics Inc.'s CAGE code is 8SAS0.

What is Immunotarget Therapeutics Inc.'s primary NAICS code?

Immunotarget Therapeutics Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Is Immunotarget Therapeutics Inc. registered in SAM.gov?

Immunotarget Therapeutics Inc.'s SAM.gov registration expired on December 6, 2025.

What is Immunotarget Therapeutics Inc.'s most recent federal award?

Immunotarget Therapeutics Inc.'s most recent federal contract award is Sbir innovative concept award - detection, diagnosis, treatment, prevention and research of pediatric cancers and/or… (75N91022C00004), from National Cancer Institute, on February 7, 2022.

On GovTribe

See Immunotarget Therapeutics Inc.'s full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login